Reimagining digital healthcare worldwide
How does our digital lab BI X innovate in Ingelheim and Shanghai? Read about success stories based on different ideation processes
Search
Digital innovation: „We change the way labs work“
QUDA – an in-house software – changes the way labs work. It increases our quality assurance and our drug saftey.
Boehringer Ingelheim Office Hours 2024: Shaping the Future of Innovation in Europe
Boehringer Ingelheim is actively supporting the next generation of innovators.
About Our Innovation Prize
Celebrating Our Innovation Prize Winners
Our innovation strategy
Our Innovation Strategy at Boehringer Ingelheim in Research and Development
Open Innovation Boehringer Ingelheim
Learn more about how we’re working across the innovation community to advance research and accelerate the development of new medicines
Animal Health Innovation
Animal Health Innovation
How Boehringer Ingelheim is Supporting Grass Roots Innovation
Our Grass Roots activities support life-science innovators with mentoring and networking opportunities
Science & Innovation
Innovation Wir verbessern die Gesundheit und die Lebensqualität von Patienten. Das ist seit 130 Jahren das zentrale Ziel des forschenden Pharmaunternehmens Boehringer Ingelheim.
Innovation in Oncology and Cancer Immunology Research
We are taking a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful, areas of cancer research.
New cancer research building: Boosting innovation in oncology
With our new cancer research building in Vienna, we’ll advance our oncology pipeline and strengthen our commitment to innovation and collaboration.
History (1990-2022): Value through Innovation
Boehringer Ingelheim's secret recipe in a constantly changing healthcare market: creating value through innovation.
Science & Innovation
We improve patients' health and quality of life. This has been the central goal of the research-based pharmaceutical company Boehringer Ingelheim for 130 years.
Human Health Innovation
Boehringer Ingelheim focuses its research activities on disease areas with a high unmet medical need.
Innovation through Collaboration
Pharmaceutical manufacturers and healthcare professionals regularly interact to learn from each other and improve patient care.
Grass Roots
Grass Roots
Data Privacy
Data protection In an increasingly digitalized world, the effective protection of personal data and the privacy of each individual plays an increasingly important role. For this reason, on May 25, 2018, the new EU General Data Protection Regulation GDPR
Boehringer Ingelheim Austria - Value through Innovation
Boehringer Ingelheim is one of the world's top 20 pharmaceutical companies with over 130 years of experience.
Partnering
We are convinced that diversity and exchange in science give birth to innovations. For this reason, partnerships are an important component of our innovation strategy.
Mental Health
Boehringer Ingelheim has a range of different compounds in development for Central Nervous System (CNS) diseases, some in advanced clinical phases.
Data Science: Revolutionizing research and development with data driven insights
Using data in pharmaceutical research to better address patient needs
Venture Fund searching for groundbreaking trends
The Boehringer Ingelheim Venture Fund acquires minority stakes in biotech start-ups, and even supports the majority before and during their founding.
Our FOCUS
Our FOCUS
Transforming pig farming: how AI helps detect respiratory disease in pigs and more
Transforming pig farming: how AI helps detect respiratory disease in pigs and more
More Health: Overview
As a company that operates at the intersection of human and veterinary medicine, we have unique opportunities to advocate for disadvantaged populations.